Cyphos Injection 1 gm/vial contains Cyclophosphamide, a potent chemotherapeutic and immunosuppressive agent used in the treatment of various cancers and autoimmune disorders. Cyclophosphamide is an alkylating agent that interferes with DNA replication in rapidly dividing cells, making it effective in controlling the growth of malignant tumors. Additionally, its immunosuppressive properties make it valuable in managing autoimmune conditions where the immune system attacks healthy tissues.

Cyphos Injection is designed for intravenous administration under strict medical supervision in hospital or clinical settings. It is commonly used for the treatment of cancers such as lymphomas, leukemia, breast cancer, and ovarian cancer, as well as autoimmune diseases like systemic lupus erythematosus, vasculitis, and severe rheumatoid arthritis.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Mechanism of Action

Cyclophosphamide is a prodrug that is metabolized in the liver to active compounds capable of forming cross-links in DNA strands. These cross-links prevent DNA replication and transcription, ultimately leading to cell death. Because rapidly dividing cells—such as cancer cells or activated immune cells—are more susceptible to DNA damage, Cyclophosphamide selectively targets these cells while sparing most normal tissues.

The drug also suppresses abnormal immune responses by reducing the proliferation of B and T lymphocytes, which helps in controlling autoimmune activity and reducing inflammation.

Indications

Cyphos Injection 1 gm/vial is indicated for:

• Various malignancies including:

  • Non-Hodgkin’s lymphoma

  • Hodgkin’s disease

  • Leukemia

  • Breast cancer

  • Ovarian cancer

• Autoimmune disorders such as:

  • Systemic lupus erythematosus (SLE)

  • Severe rheumatoid arthritis

  • Vasculitis

• Conditioning regimens prior to bone marrow transplantation

It is important that Cyphos Injection is administered by trained healthcare professionals due to its potent effects and potential for serious side effects.

Dosage and Administration

The dosage of Cyphos Injection depends on the type and severity of the condition being treated, as well as the patient’s body surface area and overall health status. It is administered intravenously, often diluted in a suitable infusion fluid, and given under close medical supervision.

Frequent monitoring of blood counts, liver function, and kidney function is essential during therapy. The dosing schedule may vary depending on whether it is being used for chemotherapy, immunosuppression, or as part of a combination regimen.

Precautions and Warnings

• Cyphos Injection should only be used under strict medical supervision.

• Patients should inform their physician of any pre-existing conditions such as liver disease, kidney impairment, or infections.

• Use caution in pregnant or breastfeeding women, as Cyclophosphamide can cause fetal harm and is excreted in breast milk.

• Protective measures should be taken by healthcare providers to prevent accidental exposure, as Cyclophosphamide is cytotoxic.

• Regular monitoring of blood cell counts is necessary to prevent severe immunosuppression and infection.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common and serious side effects include:

• Nausea and vomiting

• Hair loss (alopecia)

• Bone marrow suppression leading to low white blood cells, red blood cells, and platelets

• Increased susceptibility to infections

• Hemorrhagic cystitis (bladder irritation)

• Fatigue and weakness

• Rarely, long-term use may increase the risk of secondary cancers

Supportive therapies may be prescribed to manage side effects during treatment.

Storage Instructions

Store Cyphos Injection 1 gm/vial in a cool, dry place, protected from light. Keep out of reach of children. Reconstituted solutions should be prepared and administered immediately according to medical guidelines.

Cyphos Injection 1 gm/vial provides effective cytotoxic and immunosuppressive therapy for a range of malignant and autoimmune conditions, offering critical support in clinical oncology and specialized care settings.